{"result": "\n{\n    \"title\": \"Drotrecogin Alfa Activated and Severe Sepsis Treatment\",\n    \"summary\": \"The community centers around Drotrecogin Alfa Activated, a drug developed by Eli Lilly for the treatment of severe sepsis. Key entities include Activated Protein C, Protein C Deficiency, and various biological markers such as D-Dimer and Interleukin-6, which are involved in the drug's mechanism of action. The Independent Data and Safety Monitoring Board and the Vanderbilt Coordinating Center play crucial roles in ensuring the safety and efficacy of the clinical trials.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant role of Drotrecogin Alfa Activated in potentially reducing mortality in severe sepsis patients.\",\n    \"findings\": [\n        {\n            \"summary\": \"Drotrecogin Alfa Activated's role in severe sepsis treatment\",\n            \"explanation\": \"Drotrecogin Alfa Activated is a recombinant form of human activated protein C, used in the treatment of severe sepsis. It has demonstrated efficacy in reducing mortality rates among patients by leveraging its antithrombotic, anti-inflammatory, and profibrinolytic properties. The drug was compared against a placebo in a phase 3 trial, highlighting its potential benefits over standard treatment options [Data: Entities (275); Relationships (279, 556)].\"\n        },\n        {\n            \"summary\": \"Activated Protein C as a key mechanism\",\n            \"explanation\": \"Activated Protein C is central to the mechanism of action of Drotrecogin Alfa Activated. It exerts anti-inflammatory and antithrombotic effects, which are crucial in managing the symptoms of severe sepsis. The protein's ability to inhibit cytokine production and E-selectin-mediated cell adhesion further underscores its therapeutic potential [Data: Entities (291); Relationships (777, 784, 785)].\"\n        },\n        {\n            \"summary\": \"Impact of Protein C Deficiency\",\n            \"explanation\": \"Protein C Deficiency is a condition that affects the coagulation process in patients with severe sepsis. The presence of this deficiency was analyzed in the study, revealing its influence on the response to Drotrecogin Alfa Activated treatment. The drug showed consistent effects in patients regardless of their Protein C status, indicating its broad applicability [Data: Entities (288); Relationships (558, 774)].\"\n        },\n        {\n            \"summary\": \"Role of the Independent Data and Safety Monitoring Board\",\n            \"explanation\": \"The Independent Data and Safety Monitoring Board was instrumental in maintaining the integrity and safety of the clinical trials involving Drotrecogin Alfa Activated. By conducting interim analyses, the board ensured that the study adhered to ethical standards and provided reliable data on the drug's efficacy and safety [Data: Entities (16); Relationships (56, 57)].\"\n        },\n        {\n            \"summary\": \"Biological markers and their significance\",\n            \"explanation\": \"Several biological markers, including D-Dimer and Interleukin-6, were measured to assess the effects of Drotrecogin Alfa Activated. The reduction in D-Dimer levels indicates decreased thrombin generation, while lower Interleukin-6 levels highlight the drug's anti-inflammatory activity. These markers are critical in evaluating the drug's impact on coagulation and inflammation processes [Data: Entities (289, 290); Relationships (775, 776)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n291,ACTIVATED PROTEIN C,\"Activated protein C is a protein known for its anti-inflammatory properties and plays a significant role in the mechanism of action of drotrecogin alfa activated. It is also utilized as a treatment in clinical trials, which may influence the generalizability of the trial results.\",4\n275,DROTRECOGIN ALFA ACTIVATED,\"Drotrecogin Alfa Activated, also known as recombinant human activated protein C, is a drug used in the treatment of severe sepsis. It is known for its antithrombotic, antiinflammatory, and profibrinolytic properties. The treatment has been studied in a phase 3 trial, where it was used to reduce the rate of death from severe sepsis by decreasing inflammation and inhibiting thrombin generation. In this study, Drotrecogin Alfa Activated was compared against a placebo group to evaluate its effectiveness in reducing mortality among severe sepsis patients.\",15\n288,PROTEIN C DEFICIENCY,\"Protein C Deficiency is a condition that was analyzed in the study, where it was observed in a significant number of patients. This deficiency affects their coagulation and influences the response to Drotrecogin Alfa Activated treatment.\",2\n16,INDEPENDENT DATA AND SAFETY MONITORING BOARD,\"The Independent Data and Safety Monitoring Board was responsible for conducting interim analyses during the CORTICUS study. This board met after each of the three interim analyses to ensure the safety and integrity of the data. Their role was to assess both the efficacy and safety of the study, thereby maintaining the study's overall reliability and ethical standards.\",3\n287,CENTRAL RANDOMIZATION CENTER,The central randomization center is responsible for assigning patients to treatment groups in the study,1\n289,D-DIMER,D-Dimer is a fibrin degradation product that is measured in studies to assess the effect of Drotrecogin Alfa Activated on thrombin generation. The levels of D-Dimer decrease with treatment using Drotrecogin Alfa Activated.,1\n276,VANDERBILT COORDINATING CENTER,\"The Vanderbilt Coordinating Center in Nashville served as the clinical coordinating center for the trial, providing 24-hour support for patient eligibility and safety inquiries\",1\n277,THROMBOMODULIN,\"Thrombomodulin is a protein that, when coupled with thrombin, converts protein C to activated protein C, playing a role in modulating coagulation and inflammation during sepsis\",1\n290,INTERLEUKIN-6,Interleukin-6 is a cytokine whose levels were measured in the study to evaluate the anti-inflammatory effects of Drotrecogin Alfa Activated.,1\n292,THROMBIN,\"Thrombin is an enzyme that plays a role in blood coagulation, whose generation is inhibited by drotrecogin alfa activated\",1\n293,NEUTROPHILS,\"Neutrophils are a type of white blood cell involved in inflammation, whose activation is inhibited by drotrecogin alfa activated\",1\n294,MAST CELLS,\"Mast cells are immune cells involved in allergic reactions and inflammation, whose degranulation is decreased by drotrecogin alfa activated\",1\n295,CYTOKINES,\"Cytokines are signaling proteins that mediate and regulate immunity and inflammation, whose production is inhibited by activated protein C\",1\n296,E-SELECTIN,\"E-selectin is a cell adhesion molecule involved in the adhesion of cells to vascular endothelium, whose activity is inhibited by activated protein C\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n172,SEPTIC SHOCK,ACTIVATED PROTEIN C,The use of activated protein C in the trial may have affected the results related to septic shock,74\n279,PLACEBO GROUP,DROTRECOGIN ALFA ACTIVATED,\"In a study aimed at evaluating the efficacy of Drotrecogin Alfa Activated in treating severe sepsis, Drotrecogin Alfa Activated was compared to a placebo group. The research focused on assessing the effects of Drotrecogin Alfa Activated in patients suffering from severe sepsis, providing insights into its potential benefits over a placebo.\",50\n556,SEVERE SEPSIS,DROTRECOGIN ALFA ACTIVATED,\"Drotrecogin Alfa Activated is used as a treatment for severe sepsis. In studies and trials, it has been employed to treat patients with this condition, resulting in a reduction in the rate of death. The treatment has demonstrated a reduction in mortality and is noted to have an acceptable safety profile.\",32\n27,ELI LILLY,DROTRECOGIN ALFA ACTIVATED,Eli Lilly developed drotrecogin alfa activated for the treatment of severe sepsis,23\n117,APACHE II SCORE,DROTRECOGIN ALFA ACTIVATED,Drotrecogin Alfa Activated treatment effects were analyzed in subgroups defined by the APACHE II Score,23\n777,DROTRECOGIN ALFA ACTIVATED,ACTIVATED PROTEIN C,Drotrecogin alfa activated exerts its effects through the antiinflammatory and antithrombotic properties of activated protein C,19\n558,SEVERE SEPSIS,PROTEIN C DEFICIENCY,Protein C deficiency is a condition that affects patients with severe sepsis in the study,19\n56,INDEPENDENT DATA AND SAFETY MONITORING BOARD,DROTRECOGIN ALFA ACTIVATED,The independent data and safety monitoring board conducted interim analyses to assess the efficacy of drotrecogin alfa activated,18\n774,DROTRECOGIN ALFA ACTIVATED,PROTEIN C DEFICIENCY,Drotrecogin Alfa Activated showed consistent effects in patients with and without Protein C Deficiency,17\n773,DROTRECOGIN ALFA ACTIVATED,CENTRAL RANDOMIZATION CENTER,The central randomization center assigned patients to receive drotrecogin alfa activated or placebo,16\n775,DROTRECOGIN ALFA ACTIVATED,D-DIMER,\"Drotrecogin Alfa Activated is a therapeutic agent known for its ability to reduce plasma D-Dimer levels. This reduction in D-Dimer levels indicates a decrease in thrombin generation, showcasing the biologic activity of Drotrecogin Alfa Activated. By decreasing D-Dimer levels, Drotrecogin Alfa Activated effectively demonstrates its role in modulating coagulation processes.\",16\n771,DROTRECOGIN ALFA ACTIVATED,VANDERBILT COORDINATING CENTER,The Vanderbilt Coordinating Center provided support for the trial involving drotrecogin alfa activated,16\n772,DROTRECOGIN ALFA ACTIVATED,THROMBOMODULIN,\"Thrombomodulin is involved in the conversion process that activates protein C, which is the basis for drotrecogin alfa activated\",16\n776,DROTRECOGIN ALFA ACTIVATED,INTERLEUKIN-6,\"Drotrecogin Alfa Activated is known for its anti-inflammatory activity, as evidenced by its ability to decrease Interleukin-6 levels. This reduction in Interleukin-6, a pro-inflammatory cytokine, highlights the therapeutic potential of Drotrecogin Alfa Activated in managing inflammatory responses.\",16\n778,DROTRECOGIN ALFA ACTIVATED,THROMBIN,\"Drotrecogin alfa activated inhibits the generation of thrombin, contributing to its antiinflammatory effects\",16\n779,DROTRECOGIN ALFA ACTIVATED,NEUTROPHILS,\"Drotrecogin alfa activated inhibits the activation of neutrophils, contributing to its antiinflammatory effects\",16\n780,DROTRECOGIN ALFA ACTIVATED,MAST CELLS,\"Drotrecogin alfa activated decreases the degranulation of mast cells, contributing to its antiinflammatory effects\",16\n57,INDEPENDENT DATA AND SAFETY MONITORING BOARD,CORTICUS STUDY,The board monitored data safety and integrity during the CORTICUS study,15\n25,ELI LILLY,INDEPENDENT DATA AND SAFETY MONITORING BOARD,The independent data and safety monitoring board conducted interim analyses for the study sponsored by Eli Lilly,11\n784,ACTIVATED PROTEIN C,CYTOKINES,Activated protein C inhibits the production of cytokines by lipopolysaccharide-challenged monocytes,5\n785,ACTIVATED PROTEIN C,E-SELECTIN,Activated protein C inhibits E-selectin–mediated adhesion of cells to vascular endothelium,5\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}